The sexist behaviour of immune checkpoint inhibitors in cancer therapy?

2017113 citationsJournal Articlediamond Open Access

Authors

Andrea Botticelli · Sapienza University of Rome

Concetta Elisa Onesti · CTO Andrea Alesini

Ilaria Grazia Zizzari · Sapienza University of Rome

Bruna Cerbelli · Sapienza University of Rome

Paolo Sciattella · Sapienza University of Rome

Mario Occhipinti · CTO Andrea Alesini

Michela Roberto

Abstract

Different mechanisms could be involved in sex differences with regard to immunotherapy. These differences could be relevant to identify immunological targets in order to draw studies exploring novel combinations of immunotherapy agents.

Topics & Keywords

Cancer Immunotherapy and Biomarkers Cancer, Stress, Anesthesia, and Immune Response Immunotherapy and Immune Responses

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Oncotarget

Volume 8, Issue 59, pp. 99336-99346

DOI: 10.18632/oncotarget.22242

Field-Weighted Citation Impact: 4.12